Compare First Horizon Corporation Common Stock (FHN) vs Hims and Hers Health Inc (HIMS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
First Horizon Corporation Common Stock vs Hims and Hers Health Inc — how do they compare? First Horizon Corporation Common Stock trades at $22.63 (market cap $10.74B), while Hims and Hers Health Inc trades at $27.15 (market cap $6.47B). The key difference: First Horizon Corporation Common Stock is the larger of the two by market cap, and First Horizon Corporation Common Stock pays a 3% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold First Horizon Corporation Common Stock for 0 Days and Hims and Hers Health Inc for 21 Days on average.
| FHN | HIMS | |
|---|---|---|
Market Cap | $10.74B | $6.47B |
Volume | 11,773,440 | 10,989,212 |
Sector | Financials | Health |
52-Week High | $26.23 | $62.76 |
52-Week Low | $19.94 | $14.52 |
Typical Hold Time | 0 Days | 21 Days |
Enterprise Value | $14.03B | $7.17B |
Dividend Yield | 3% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
First Horizon (FHN) trades at $22.77, down 1.26% on the day, with a neutral technical outlook. The stock shows strong fundamentals, including a P/E of 10.95 and net income margin of 30.87% for 2026, supported by three consecutive quarterly earnings beats. Recent news highlights executive recognitions and upcoming Q3 2026 earnings on October 15, 2026.
The outlook is positive given robust profitability, analyst consensus price target of $27.44 (20.5% upside), and no sell ratings. Risks include high debt-to-asset ratio of 1.81 and macroeconomic sensitivity. Earnings growth remains the key catalyst for further upside, with investor focus on Q3 results.
Hims & Hers Health (HIMS) trades at $29.71, down 3.04% on the day, amid a securities class action lawsuit. Technical indicators show a bullish trend, with support near $29 and resistance at $32. Fundamentally, the company reported $2.35B in 2025 revenue but swung to a net loss of -$142M in 2026, with a negative net margin of -5.51%. Valuation ratios are elevated, with a P/E of 57.14 and EV/EBITDA of 205.86. Analyst consensus is a 'Hold' with a $32.17 price target, while recent news is dominated by legal actions.
The outlook for HIMS is clouded by legal overhangs and profitability challenges despite top-line growth. Investment opportunity hinges on resolving litigation and returning to profitability, but risks include regulatory scrutiny and execution missteps. The stock's high valuation multiples require strong future earnings to justify, making it speculative in the near term.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About First Horizon Corporation Common Stock
First Horizon Corporation is the holding company for First Horizon Bank, a regional financial services provider operating roughly 460 branches across 11 states in southeastern US. It offers commercial, consumer, private banking, wealth management, and capital markets services.
Read more on FHN →About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →
